It is also known by the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Polypharmacy: Patients taking multiple medications, particularly those with narrow therapeutic indices or significant interaction potential, should have their complete regimen reviewed by a pharmacist or physician
Clinical decisions should therefore remain individualized, and continued long-term surveillance is warranted
The medication comes in two forms: weekly subcutaneous injections and daily oral tablets
Its multi-state physical presence, with locations in NY, PA, VA, SC, TX, FL, and AZ, means patients in many regions have access to a nearby physical location as well as mail-order dispensing
The Zepbound label lists changes in vision as a possible tirzepatide side effect of diabetic retinopathy